Main Finding: One dose of adjuvant vaccine may protect young children against 2009 H1N1 influenza.
Data Source: A randomized trial of three dosing regimens of H1N1 vaccines, including 194 children aged 3-8 years.
Disclosures: The study was sponsored by Novartis, which manufactured the vaccines used. Study coauthor Dr. Kelly Lindert is an employee of Novartis Vaccines and Diagnostics in Cambridge, Mass.
PREVIEW